Montag & Associates’s MiMedx Group MDXG Stock Holding History

Montag & Associates’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,000	Closed	-$14K	–	1079
2025 Q3	$14K	Hold	2,000	–	–	﹤0.01%	721
2025 Q2	$12.2K	Hold	2,000	–	–	﹤0.01%	728
2025 Q1	$15.2K	Hold	2,000	–	–	﹤0.01%	743
2024 Q4	$19.2K	Hold	2,000	–	–	﹤0.01%	715
2024 Q3	$11.8K	Hold	2,000	–	–	﹤0.01%	790
2024 Q2	$13.9K	Hold	2,000	–	–	﹤0.01%	743
2024 Q1	$15.4K	Hold	2,000	–	–	﹤0.01%	721
2023 Q4	$17.5K	Hold	2,000	–	–	﹤0.01%	706
2023 Q3	$14.6K	Hold	2,000	–	–	﹤0.01%	697
2023 Q2	$13.2K	Hold	2,000	–	–	﹤0.01%	718
2023 Q1	$6.82K	Hold	2,000	–	–	﹤0.01%	792
2022 Q4	$5.56K	Hold	2,000	–	–	﹤0.01%	807
2022 Q3	$6K	Hold	2,000	–	–	﹤0.01%	771
2022 Q2	$7K	Hold	2,000	–	–	﹤0.01%	725
2022 Q1	$9K	Hold	2,000	–	–	﹤0.01%	732
2021 Q4	$12K	Hold	2,000	–	–	﹤0.01%	715
2021 Q3	$12K	Hold	2,000	–	–	﹤0.01%	713
2021 Q2	$25K	Hold	2,000	–	–	﹤0.01%	641
2021 Q1	$21K	Hold	2,000	–	–	﹤0.01%	660
2020 Q4	$18K	Buy	+2,000	New	+$14.4K	﹤0.01%	649

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Montag & Associates's MDXG Position: Q4 2025 in Review

Montag & Associates sold out of MiMedx Group (MDXG) in Q4 2025, closing a stake of 2,000 shares — an estimated $14K sold.

Montag & Associates first reported a position in MDXG in Q4 2020 and held it in 20 quarters. The position peaked at $25K in Q2 2021. 233 funds tracked by Wall St. Rank hold MDXG as of Q4 2025.

Montag & Associates reported no remaining MiMedx Group position as of Q4 2025 after selling out during the quarter.
Montag & Associates sold 2,000 MiMedx Group shares in Q4 2025, an estimated $14K.
Montag & Associates first reported a position in MiMedx Group in Q4 2020 and held it in 20 quarters.
Montag & Associates's MiMedx Group position peaked at $25K in Q2 2021.
233 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2025.

Based on Montag & Associates's 13F filing for Q4 2025, filed 2 Feb 2026.